Authors:
LOWN KS
MAYO RR
LEICHTMAN AB
HSIAO HL
TURGEON DK
SCHMIEDLINREN P
BROWN MB
GUO WS
ROSSI SJ
BENET LZ
WATKINS PB
Citation: Ks. Lown et al., ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE, Clinical pharmacology and therapeutics, 62(3), 1997, pp. 248-260
Citation: Rj. Fontana et al., THE CAFFEINE BREATH TEST DOES NOT IDENTIFY PATIENTS SUSCEPTIBLE TO TACRINE HEPATOTOXICITY, Hepatology, 23(6), 1996, pp. 1429-1435
Citation: Fr. Liewehr et al., EFFECT OF BISPHOSPHONATES AND GALLIUM ON DENTIN RESORPTION IN-VITRO, Endodontics & dental traumatology, 11(1), 1995, pp. 20-26
Authors:
JAFFE CA
TURGEON DK
FRIBERG RD
WATKINS PB
BARKAN AL
Citation: Ca. Jaffe et al., NOCTURNAL AUGMENTATION OF GROWTH-HORMONE (GH) SECRETION IS PRESERVED DURING REPETITIVE BOLUS ADMINISTRATION OF GH-RELEASING HORMONE - POTENTIAL INVOLVEMENT OF ENDOGENOUS SOMATOSTATIN - A CLINICAL RESEARCH-CENTER STUDY, The Journal of clinical endocrinology and metabolism, 80(11), 1995, pp. 3321-3326
Authors:
HENDERSON JM
BARNETT JL
TURGEON DK
ELTA GH
BEHLER EM
CRAUSE I
NOSTRANT TT
Citation: Jm. Henderson et al., SINGLE-DAY, DIVIDED-DOSE ORAL SODIUM-PHOSPHATE LAXATIVE VERSUS INTESTINAL LAVAGE AS PREPARATION FOR COLONOSCOPY - EFFICACY AND PATIENT TOLERANCE, Gastrointestinal endoscopy, 42(3), 1995, pp. 238-243
Citation: Ks. Lown et al., INTERINDIVIDUAL VARIATION IN INTESTINAL MDR1 EXPRESSION - LACK OF SHORT-TERM DIET EFFECTS, Gastroenterology, 108(4), 1995, pp. 737-737
Authors:
LOWN KS
THUMMEL KE
BENEDICT PE
SHEN DD
TURGEON DK
BERENT S
WATKINS PB
Citation: Ks. Lown et al., THE ERYTHROMYCIN BREATH TEST PREDICTS THE CLEARANCE OF MIDAZOLAM, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 16-24
Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF CAFFEINE TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Hepatology, 19(4), 1994, pp. 90000063-90000063
Citation: Dk. Turgeon et al., PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG-37-325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST - A PROSPECTIVE-STUDY IN RENAL-TRANSPLANT RECIPIENTS, Transplantation, 57(12), 1994, pp. 1736-1741
Citation: Rj. Fontana et al., TACRINE HEPATOTOXICITY - THE USE OF METABOLIC PROBES TO IDENTIFY POTENTIAL SUSCEPTIBILITY FACTORS, Gastroenterology, 106(4), 1994, pp. 10000893-10000893
Citation: Dk. Turgeon et al., P450 3A ACTIVITY AND CYCLOSPORINE DOSING IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS, Clinical pharmacology and therapeutics, 56(3), 1994, pp. 253-260
Authors:
WATKINS PB
TURGEON DK
GUTHRIE SK
REMEN AL
GRUNHAUS L
Citation: Pb. Watkins et al., P450IIIA (CYP3A) ACTIVITY IN SEVERELY DEPRESSED-PATIENTS, Journal of clinical psychopharmacology, 13(5), 1993, pp. 366-368